Cargando…

Transition in Sickle Cell Disease (SCD): A German Consensus Recommendation

Sickle cell disease (SCD) is considered a rare disease in Germany. Due to the increasing prevalence, the acute and chronic morbidities associated with the disease and the sharp increase in the mortality rate of young adults, a need-based transition structure for patients with SCD in Germany is expli...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alashkar, Ferras, Aramayo-Singelmann, Carmen, Böll, Janine, Hoferer, Annette, Jarisch, Andrea, Kamal, Haytham, Oevermann, Lena, Schwarz, Michaela, Cario, Holger
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9325299/ https://www.ncbi.nlm.nih.gov/pubmed/35887653 http://dx.doi.org/10.3390/jpm12071156

Ejemplares similares

Pregnancies and Neonatal Outcomes in Patients with Sickle Cell Disease (SCD): Still a (High-)Risk Constellation?
por: Proske, Pia, et al.
Publicado: (2021)

P1480: SPLENIC SEQUESTRATION IS MORE COMMON IN SCD-S/Β0-THAL THAN IN SCD-S/S PATIENTS: RESULTS FROM THE GERMAN SCD REGISTRY
por: Allard, P., et al.
Publicado: (2022)

Screening and diagnosis of hemoglobinopathies in Germany: Current state and future perspectives
por: Aramayo-Singelmann, Carmen, et al.
Publicado: (2022)

Introduction of Universal Newborn Screening for Sickle Cell Disease in Germany—A Brief Narrative Review
por: Lobitz, Stephan, et al.
Publicado: (2021)

Genetic modifiers of fetal hemoglobin affect the course of sickle cell disease in patients treated with hydroxyurea
por: Allard, Pierre, et al.
Publicado: (2021)

Benefits of a Disease Management Program for Sickle Cell Disease in Germany 2011–2019: The Increased Use of Hydroxyurea Correlates with a Reduced Frequency of Acute Chest Syndrome
por: Kunz, Joachim B., et al.
Publicado: (2021)

coreSCD: multi-stakeholder consensus on core outcomes for sickle cell disease clinical trials
por: Tambor, Ellen, et al.
Publicado: (2021)

5613004 NEWBORN SCREENING FOR SICKLE CELL DISEASE IN GERMANY - THE FIRST YEAR
por: Lobitz, S., et al.
Publicado: (2023)

The Neonatal Screening Program in Brazil, Focus on Sickle Cell Disease (SCD)
por: Silva-Pinto, Ana C., et al.
Publicado: (2019)

Liver Iron Content (LIC) in Adults with Sickle Cell Disease (SCD): Correlation with Serum Ferritin and Liver Enzymes Concentrations in Trasfusion Dependent (TD-SCD) and Non-Transfusion Dependent (NT-SCD) Patients
por: Yassin, Mohamed, et al.
Publicado: (2017)

P-004: HEALTH CARE TRANSITION (HCT) FOR SICKLE CELL DISEASE (SCD) CAN BE STANDARDIZED: RESULTS OF IMPLEMENTING A SCD HCT LEARNING COLLABORATIVE.
por: I., OSUNKWO, et al.
Publicado: (2022)

Effects of home-based inspiratory muscle training on sickle cell disease (SCD) patients
por: Galvão, Fábio, et al.
Publicado: (2021)

P110: CLINICAL CHARACTERISTICS OF COVID-19 IN SICKLE CELL DISEASE (SCD) PATIENTS
por: Malhan, H, et al.
Publicado: (2022)

Moyamoya Syndrome (MMS) in a Patient With Sickle Cell Disease (SCD) and Protein S Deficiency
por: Saxena, Parima, et al.
Publicado: (2023)

Sickle Cell Disease (SCD) Leading to Pulmonary Arterial Hypertension (PAH) and Cholelithiasis (CL)
por: Chacko, Saran, et al.
Publicado: (2023)

Neuropsychological assessment, neuroimaging, and neuropsychiatric evaluation in pediatric and adult patients with sickle cell disease (SCD)
por: Edwards, Christopher L, et al.
Publicado: (2007)

MR-Augmented Cardiopulmonary Exercise Testing- a proof of concept in Sickle Cell Disease (SCD)
por: Ako, Emmanuel O, et al.
Publicado: (2016)

The Sickle Cell Disease Functional Assessment (SCD-FA) tool: a feasibility pilot study
por: Oyedeji, Charity I., et al.
Publicado: (2022)

Radiological manifestation of avascular necrosis (AVN) in sickle cell disease (SCD): a review of diagnostic imaging
por: Mohamed Aziz Bedair, Elsaid, et al.
Publicado: (2023)

Advancements in Sickle Cell Disease (SCD) Treatment: A Review of Novel Pharmacotherapies and Their Impact on Patient Outcomes
por: Khan, Salman J, et al.
Publicado: (2023)

Cytopenia first – hepatitis second: an unusual sequence in aplastic anemia
por: Alashkar, Ferras, et al.
Publicado: (2017)

PB2214: SCD POPULATION SURVEY IN ALBANIA, A PROSPECTIVE NON-INTERVENTIONAL MULTI-CENTER STUDY EVALUATING DISEASE AND PATIENTS CHARACTERISTICS OF SICKLE CELL DISEASE IN ALBANIAN SCD POPULATION
por: Cili, A., et al.
Publicado: (2022)

Routine Paediatric Sickle Cell Disease (SCD) Outpatient Care in a Rural Kenyan Hospital: Utilization and Costs
por: Amendah, Djesika D., et al.
Publicado: (2013)

48847 Assessing Transition Outcomes in Sickle Cell Disease (SCD) Prior To Implementation of A Formal Transition Program
por: Sheppard, Sydney, et al.
Publicado: (2021)

Heterogeneity of βs gene haplotypes in patients with sickle cell disease (SCD) in Oman: A review of relevant publications
por: Al-Mashaikhi, Nawal, et al.
Publicado: (2022)

S131: REGIONAL ASSESSMENT OF THE EXPERIENCES OF HEALTHCARE PROFESSIONALS (HCPS) TREATING PATIENTS WITH SICKLE CELL DISEASE (SCD): THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
por: Osunkwo, I, et al.
Publicado: (2022)

World Coalition on SCD launches, sparking global focus on SCD diagnosis and care
por: Zapfel, Andrew, et al.
Publicado: (2023)

P-010: TREATMENTS FOR SICKLE CELL DISEASE (SCD) AND THE HEALTHCARE PROFESSIONAL (HCP)–PATIENT RELATIONSHIP: HCP OPINIONS FROM THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
por: B., ANDEMARIAM, et al.
Publicado: (2022)

Clinical findings associated with homozygous sickle cell disease in the Barbadian population – do we need a national SCD registry?
por: Quimby, Kim R, et al.
Publicado: (2014)

Identification of therapeutic targets for inflammation in sickle cell disease (SCD) among Indian patients using gene expression data analysis
por: Das, Ipsita, et al.
Publicado: (2018)

Effectiveness of a home-based therapeutic exercise program on lower back pain and functionality in Sickle Cell Disease (SCD) patients
por: Zanoni, Camila Tatiana, et al.
Publicado: (2021)

438 “How do you define Resilience?” Examining the Psychological Resilience of Black Adults Living with Sickle Cell Disease (SCD)
por: Conn, Corinne April Iolanda, et al.
Publicado: (2022)

Clinical and epidemiological features and therapeutic options of avascular necrosis in patients with sickle cell disease (SCD): A cross-sectional study
por: Alshurafa, Awni, et al.
Publicado: (2023)

Evaluation of lung function in a German single center cohort of young patients with sickle cell disease using EIT and standard techniques
por: Rein, Alina, et al.
Publicado: (2023)

Risk of classical Kaposi sarcoma by plasma levels of Epstein-Barr virus antibodies, sCD26, sCD23 and sCD30
por: Pelser, Colleen, et al.
Publicado: (2010)

P1467: HEALTHCARE PROFESSIONALS (HCP) OPINIONS ON TREATMENTS FOR SICKLE CELL DISEASE (SCD) AND THE HCP–PATIENT RELATIONSHIP: RESULTS FROM THE INTERNATIONAL SICKLE CELL WORLD ASSESSMENT SURVEY (SWAY)
por: Andemariam, B., et al.
Publicado: (2022)

No evidence for hypogammaglobulinemia in patients with paroxysmal nocturnal hemoglobinuria (PNH) chronically treated with ravulizumab
por: Alashkar, Ferras, et al.
Publicado: (2020)

Sickle Cell Disease (SCD) As a Risk for COVI19 Compared to Those without SCD Among Patients Admitted in a Large Urban Center, As Estimated By PCR Sars-v-2 Positive Vs Negative Testing
por: Adamkiewicz, Tom, et al.
Publicado: (2021)

Corrigendum: Evaluation of lung function in a German single center cohort of young patients with sickle cell disease using EIT and standard techniques
por: Rein, Alina, et al.
Publicado: (2023)

The German S3 guideline on titanium hypersensitivity in implant dentistry: consensus statements and recommendations
por: Müller-Heupt, Lena Katharina, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_im1907b233ocl320go03afldmf